Birdwatch Note
2023-11-25 22:54:59 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
There is not enough evidence to prove that Burzynski's antineoplastons discovery is a cure to cancer. The experiments he conducted had methodological flaws that made them unfit to be approved by the FDA, and studies by other investigators were unable to duplicate his results. https://www.reuters.com/article/factcheck-antineoplaston-burzynski-cance/fact-check-antineoplastons-not-a-proven-cancer-cure-and-not-an-approved-treatment-idUSL1N34O1TN/
Written by D35BC5F5E4F17548332E37B607B412240117F16C93D43F2DC90F6DB18D9D1D38
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1728466139812856097
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1728547860994462162
- noteId - 1728547860994462162
- participantId -
- noteAuthorParticipantId - D35BC5F5E4F17548332E37B607B412240117F16C93D43F2DC90F6DB18D9D1D38 Participant Details
- createdAtMillis - 1700952899583
- tweetId - 1728466139812856097
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- There is not enough evidence to prove that Burzynski's antineoplastons discovery is a cure to cancer. The experiments he conducted had methodological flaws that made them unfit to be approved by the FDA, and studies by other investigators were unable to duplicate his results. https://www.reuters.com/article/factcheck-antineoplaston-burzynski-cance/fact-check-antineoplastons-not-a-proven-cancer-cure-and-not-an-approved-treatment-idUSL1N34O1TN/
Note Status History
| createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
| 2023-11-25 22:54:59 UTC (1700952899583) |
1969-12-31 23:59:59 UTC (-1) |
2023-11-26 03:30:36 UTC (1700969436505) |
NEEDS_MORE_RATINGS | 1969-12-31 23:59:59 UTC (-1) |
Note Ratings
| rated at | rated by | |
| 2023-11-25 18:20:27 -0600 | Rating Details | |
| 2023-11-25 18:05:40 -0600 | Rating Details | |
| 2023-11-25 17:25:57 -0600 | Rating Details | |
| 2023-11-25 17:15:48 -0600 | Rating Details | |
| 2023-11-25 17:06:52 -0600 | Rating Details | |
| 2023-11-26 10:41:27 -0600 | Rating Details | |
| 2023-11-26 08:42:58 -0600 | Rating Details | |
| 2023-11-26 07:32:43 -0600 | Rating Details | |
| 2023-11-26 04:27:25 -0600 | Rating Details | |
| 2023-11-25 23:35:29 -0600 | Rating Details | |
| 2023-11-25 22:01:08 -0600 | Rating Details | |
| 2023-11-25 21:08:23 -0600 | Rating Details | |
| 2023-11-25 19:01:24 -0600 | Rating Details | |
| 2023-11-25 18:55:59 -0600 | Rating Details | |
| 2023-11-25 18:46:01 -0600 | Rating Details | |
| 2023-11-25 18:36:12 -0600 | Rating Details | |
| 2023-11-26 11:29:47 -0600 | Rating Details | |
| 2023-11-26 11:09:15 -0600 | Rating Details | |
| 2023-11-26 10:48:42 -0600 | Rating Details | |
| 2023-11-26 09:16:17 -0600 | Rating Details | |
| 2023-11-26 08:44:21 -0600 | Rating Details | |
| 2023-11-26 04:58:01 -0600 | Rating Details | |
| 2023-11-26 02:18:39 -0600 | Rating Details | |
| 2023-11-26 00:06:18 -0600 | Rating Details | |
| 2023-11-25 23:02:33 -0600 | Rating Details | |
| 2023-11-25 21:28:27 -0600 | Rating Details | |
| 2023-11-25 18:41:56 -0600 | Rating Details | |
| 2023-11-25 18:04:00 -0600 | Rating Details | |
| 2023-11-25 18:00:25 -0600 | Rating Details | |
| 2023-11-25 17:16:55 -0600 | Rating Details | |
| 2023-11-25 17:09:25 -0600 | Rating Details | |
| 2023-11-25 17:03:56 -0600 | Rating Details | |
| 2023-11-25 16:58:10 -0600 | Rating Details | |
| 2023-11-26 22:47:08 -0600 | Rating Details | |
| 2023-11-26 03:47:03 -0600 | Rating Details | |
| 2023-11-26 01:12:10 -0600 | Rating Details | |
| 2023-11-25 19:37:34 -0600 | Rating Details | |
| 2023-11-25 18:59:24 -0600 | Rating Details | |
| 2023-11-25 18:20:30 -0600 | Rating Details |